AbbVie

Abstract modern white spiral clock dial with roman and arabic numerals
Biotech

Aldeyra dry eye disease decision hit by FDA delay

The delay comes after the regulator sent a draft label for the drug candidate to the company in early December and Aldeyra responded with comments.
Darren Incorvaia Dec 16, 2025 11:55am
A ballpoint pen rests on top of a stack of documents ready for signing

AbbVie hands back phase 1 duties for inflammation drug to Ose

Dec 8, 2025 5:39am
Aerial view of Montreal Old Port in autumn

AbbVie seeks biotech applicants for Canadian innovation award

Nov 25, 2025 12:00pm
scissor cutting rope

AbbVie to end Calico collab, lay off scientists: Stat

Nov 13, 2025 3:59pm
close up of a beautiful dragonfly

AbbVie halts development of Dragonfly cancer asset in midflight

Oct 29, 2025 1:47pm
ZigZag zigging zagging

Zag Bio emerges with $80M funding for Tregs diabetes candidate

Oct 28, 2025 7:00am